glp-1 and osteoarthritis The potential role of GLP‐1 receptor agonists in - Ryan - 2025 - Pharmacotherapy: The Journal of Human Pharmacology Drug Therapy Stories like this are why

Toujeo sounds vaguely pharmaceutical

The visible results of inflammation reduction include reduced facial puffiness, improved skin quality (clearer, more even tone, reduced redness), decreased joint swelling and pain, improved eye appearance (reduced under-eye bags and redness), and a general appearance of vitality that people describe as looking younger and healthier

Foods and supplements that score low on the FODMAP scale tend to go down easy and are more readily digestible, especially for those struggling with tummy issues already

FDA Disclaimer Statements regarding this product have not been evaluated by the Food and Drug Administration

This mini-review explores the role of gut peptides, particularly glucagonlike peptide-1 (GLP-1), in the improvement in glycemic control resulting from VSG and RYGB procedures

The primary concerns include gastrointestinal side effects (nausea, diarrhoea, abdominal pain) that may be difficult to distinguish from UC flares, increased dehydration risk, and the challenge of monitoring disease activity whilst on treatment